ES480351A1 - Procedimiento para la obtencion de 1,4-dihidropiridinas ni- tro-sustituidas. - Google Patents

Procedimiento para la obtencion de 1,4-dihidropiridinas ni- tro-sustituidas.

Info

Publication number
ES480351A1
ES480351A1 ES480351A ES480351A ES480351A1 ES 480351 A1 ES480351 A1 ES 480351A1 ES 480351 A ES480351 A ES 480351A ES 480351 A ES480351 A ES 480351A ES 480351 A1 ES480351 A1 ES 480351A1
Authority
ES
Spain
Prior art keywords
dihydropyridines
nitro
manufacture
medicaments containing
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES480351A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES480351A1 publication Critical patent/ES480351A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Procedimiento para la obtención de 1,4- dihidropiridinas nitro-sustituidas de fórmula general I **(Fórmula)** donde R significa hidrógeno o un resto alquilo de cadena recta o ramificada que, en caso dado, puede estar interrumpido en la cadena alquilo por 1 a 2 átomos de oxígeno, o un resto arilo o aralquilo, R1 y R4 significan hidrógeno, un resto alquilo de cadena recta o ramificada, un resto arilo, un resto aralquilo o un resto heteroarilo, R2 significa hidrógeno, un grupo nitro o el grupo COR5, donde R5 bien significa un resto alquilo, arilo o aralquilo, o R5 significa el grupo OR6 representa un resto hidrocarburo de cadena recta, ramificada o cíclica, saturado o insaturado, que en caso dado está interrumpido por 1 a 2 átomos de oxígeno o de azufre en la cadena, o donde un átomo de hidrógeno puede estar sustituido por un grupo fenoxi o fenilo.
ES480351A 1977-11-26 1979-05-08 Procedimiento para la obtencion de 1,4-dihidropiridinas ni- tro-sustituidas. Expired ES480351A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772752820 DE2752820A1 (de) 1977-11-26 1977-11-26 Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ES480351A1 true ES480351A1 (es) 1979-12-01

Family

ID=6024688

Family Applications (3)

Application Number Title Priority Date Filing Date
ES475379A Expired ES475379A1 (es) 1977-11-26 1978-11-24 Procedimiento para la obtencion de 1,4-dihidropiridinas ni- tro-sustituidas
ES480350A Expired ES480350A1 (es) 1977-11-26 1979-05-08 Procedimiento para la obtencion de 1,4-dihidropiridinasnitrosustituidas.
ES480351A Expired ES480351A1 (es) 1977-11-26 1979-05-08 Procedimiento para la obtencion de 1,4-dihidropiridinas ni- tro-sustituidas.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES475379A Expired ES475379A1 (es) 1977-11-26 1978-11-24 Procedimiento para la obtencion de 1,4-dihidropiridinas ni- tro-sustituidas
ES480350A Expired ES480350A1 (es) 1977-11-26 1979-05-08 Procedimiento para la obtencion de 1,4-dihidropiridinasnitrosustituidas.

Country Status (7)

Country Link
US (1) US4248873A (es)
EP (1) EP0002208B1 (es)
JP (1) JPS5481279A (es)
AT (1) AT368492B (es)
DE (2) DE2752820A1 (es)
ES (3) ES475379A1 (es)
IT (1) IT1100185B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA792608B (en) * 1978-05-30 1980-06-25 Smith Kline French Lab Nitro compounds
US4405624A (en) * 1978-05-30 1983-09-20 Smith Kline & French Laboratories Limited Nitro-substituted dihydropyrroles and tetrahydropyridines, compositions, compounds, and medicinal use
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3206671A1 (de) * 1982-02-25 1983-09-01 Bayer Ag, 5090 Leverkusen Dihydropyridine mit positiv inotroper wirkung, neue verbindungen, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
DE3130041A1 (de) * 1981-07-30 1983-02-17 Bayer Ag, 5090 Leverkusen Dihydropyridine mit positiv inotroper wirkung, neue verbindungen, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
DE3319956A1 (de) * 1983-06-01 1984-12-06 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3326384A1 (de) * 1983-07-22 1985-01-31 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
FR2554109A1 (fr) * 1983-11-01 1985-05-03 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments
DE3420784A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 3-nitro-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3445852A1 (de) * 1984-12-15 1986-06-19 Bayer Ag, 5090 Leverkusen Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3447170A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Mischung unterschiedlicher dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
DE3501855A1 (de) * 1985-01-22 1986-07-24 Bayer Ag, 5090 Leverkusen 5-aryl-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3517473A1 (de) * 1985-05-15 1986-11-20 Bayer Ag, 5090 Leverkusen Pyrimidinyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
NO881411L (no) * 1987-04-14 1988-10-17 Bayer Ag Substituerte pyrroler.
DE3724909A1 (de) * 1987-07-28 1989-02-09 Bayer Ag Neue substituierte nitro-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
DE3732380A1 (de) * 1987-09-25 1989-04-06 Bayer Ag Dihydropyridinether, verfahren zu ihrer herstellung und ihre verwendung
MY104933A (en) * 1987-09-30 1994-07-30 Pfizer Ltd Platelet activating factor antagonists
DE3737340A1 (de) * 1987-11-04 1989-05-24 Bayer Ag Neue fluormethoxyphenyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
DE3737341A1 (de) * 1987-11-04 1989-05-18 Bayer Ag Neue fluormethoxyphenyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
DE3800785A1 (de) * 1988-01-09 1989-07-20 Hoechst Ag Substituierte 7-(pyridazin-5-yl)-3,5-dihydroxyheptan(en)- saeuren, ihre entsprechenden (delta)-lactone bzw. derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
DE4011105A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue 4-chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5254692A (en) * 1990-04-06 1993-10-19 Bayer Aktiengesellschaft 2,6-dialkyl-4-(benzothiazol- or benzoxazol-7-yl)-1,4-dihydropyridines
US5204472A (en) * 1990-04-06 1993-04-20 Bayer Aktiengesellschaft Quinoline and isoquinoline intermediates
US5166148A (en) * 1990-07-09 1992-11-24 The Du Pont Merck Pharmaceutical Company 2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
DE4134760A1 (de) * 1991-10-22 1993-07-08 Bayer Ag Aryl-chinolyl-substituierte 1,4-dihydropyridin-dicarbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4202526A1 (de) * 1992-01-30 1993-08-05 Bayer Ag Neue 4-cinnolinyl- und 4-naphthyridinyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4313692A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 3-Chinolyl substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313690A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313697A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Chinolyl-dihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313691A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2,6-Disubstituierte 4-Chinolyl-dihydropyridine
EP2884884A1 (en) 2012-08-16 2015-06-24 École Polytechnique Fédérale de Lausanne (EPFL) Method and apparatus for low complexity spectral analysis of bio-signals

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2310747A1 (de) * 1973-03-03 1974-09-12 Bayer Ag Verfahren zur herstellung von neuen amino-3,4-dihydropyridinen und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
JPS5481279A (en) 1979-06-28
IT1100185B (it) 1985-09-28
ES475379A1 (es) 1979-10-16
ATA841778A (de) 1982-02-15
DE2752820A1 (de) 1979-05-31
US4248873A (en) 1981-02-03
IT7830192A0 (it) 1978-11-24
EP0002208B1 (de) 1981-03-11
EP0002208A1 (de) 1979-06-13
JPS6132308B2 (es) 1986-07-25
AT368492B (de) 1982-10-11
DE2860529D1 (en) 1981-04-09
ES480350A1 (es) 1980-01-01

Similar Documents

Publication Publication Date Title
ES475379A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas ni- tro-sustituidas
EG12773A (en) Processes for the preparation of amidinoureas,the amidinoureas thus produced and compositions incorporating them
IL51076A (en) Glucosamine-3-alkanoyl-dipeptides, their manufacture and ppharmaceutical compositions containing them
IL50011A (en) N-substituted3-trifuloromethyl-phenyl-n-benzoyl ureas,their preparation and insecticidal compositions containing the
ES472641A1 (es) Procedimiento para la obtencion de propenil-aminas
IL49289A0 (en) Novel n-substituted halo-2-pyrrolidinones,their preparation and their use as herbicides
ES451117A1 (es) Un procedimiento para preparar 3-piridil-isoxazolidinas.
ES475633A1 (es) Procedimiento para la obtencion de derivados de 1-n-4,6-di-0-(aminoglicosil)-1,3-diamino-ciclitol.
ES448588A1 (es) Un procedimiento para la preparacion de un compuesto hetero-arilico.
ES478048A1 (es) Procedimiento para la obtencion de difenil-imidazolil-meta- nos sustituidos.
IL49972A (en) 2,4-diamino-pyrimidine derivatives their manufacture and herbicidal compositions containing them
ZA763211B (en) Analgetic compositions
NZ182740A (en) 7 -acylamido-7 -methoxy-cephalospoims,and prarmaceutical compositions
IL50758A0 (en) 1-(2-halogeno-2-phenyl-ethyl)-triazoles,their preparation and fungicidal compositions containing them
IL50792A (en) 1,4-diphenyl-3-pyrazolin-5-ones their preparation and herbicidal compositions containing them
IL54591A0 (en) Novel benzimidazole derivatives, their manufacture and pharmaceutical compositions containing them
IL50170A0 (en) Herbicidal compositions containing certain pyridazone-(6)derivatives,their production and their use
IL55832A0 (en) Novel 2-imino-imidazilidine derivatives,their manufacture and pharmacheutical compositions containing them
IL50560A (en) N-(1-alkylthiocarbonylacetyl)-n-substituted acetyl-aniline derivatives,their manufacture and fungicidal and bactericidal compositions containing them
ES473316A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas.
IL53925A0 (en) Novel oxadiazolopyrimidine derivatives, their manufacture and pahrmaceutical compositions containing them
IL55018A0 (en) Novel benzylpyrimidines, their manufacture and pharmaceutical compositions containing them
HU175879B (en) Herbicide compositions containing substituted pyridazone and process for producing the active agents
ZA761713B (en) Novel 2,3-dihalogen-alkanoyl-ureas and their use as fungicides
IT7830071A0 (it) 2-adamantil idrazine e composizioni che le contengono.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603